FDA Approves Extended Adjuvant Therapy for Early-Stage Breast Cancer (FREE)

By Kristin J. Kelley Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM The FDA has approved neratinib (brand name, Nerlynx) for reducing the risk for breast cancer recurrence. The drug — the …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news